Postlicensure Monitoring of Intussusception After RotaTeq Vaccination in the United States, February 1, 2006, to September 25, 2007
Penina Haber, Umesh D. Parashar(Centers for Disease Control and Prevention), Robert Ball(Center for Drug Evaluation and Research), Héctor S. Izurieta(Center for Biologics Evaluation and Research), Edward A. Belongia(Marshfield Clinic), Eric Weintraub, Margaret M. Cortese(Centers for Disease Control and Prevention), Manish Patel(Centers for Disease Control and Prevention), John Iskander, M. Miles Braun(Center for Biologics Evaluation and Research), Paul Gargiullo(Centers for Disease Control and Prevention), Elaine R. Miller(National Center for Emerging and Zoonotic Infectious Diseases), James Baggs
Cited by 115
Related Papers
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
|New England Journal of Medicine|2001|3.7k
Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans
|Science|2009|2.5k
Global Illness and Deaths Caused by Rotavirus Disease in Children
|Emerging infectious diseases|2003|1.9k
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
|The Lancet Infectious Diseases|2011|1.8k
Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug Administration
|Arthritis & Rheumatism|2002|661